p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cellsRobert J. Ihry, Ajamete Kaykas, Daniel Ho et al.|Nature Medicine|2018Cited by 1k
P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cellsRobert J. Ihry, Ajamete Kaykas, Kathleen A. Worringer et al.|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 7